JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M502272200 on May 26, 2005

J. Biol. Chem., Vol. 280, Issue 30, 27924-27934, July 29, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
280/30/27924    most recent
M502272200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barthet, G.
Right arrow Articles by Dumuis, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barthet, G.
Right arrow Articles by Dumuis, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Uncoupling and Endocytosis of 5-Hydroxytryptamine 4 Receptors

DISTINCT MOLECULAR EVENTS WITH DIFFERENT GRK2 REQUIREMENTS*{boxs}

Gaël Barthet{ddagger}, Florence Gaven{ddagger}, Bérénice Framery{ddagger}, Katsuhiro Shinjo§, Takaaki Nakamura§, Sylvie Claeysen{ddagger}, Joël Bockaert{ddagger}, and Aline Dumuis{ddagger}

From the {ddagger}CNRS UMR5203, Montpellier, F-34094 France, INSERM, U661, Montpellier, F-34094 France, Université Montpellier I, Montpellier, F-34094 France, Université Montpellier II, Montpellier, F-34094 France, Institut de Génomique Fonctionnelle, 141 Rue de la Cardonille, Montpellier F-34094 Cedex 5, France, and §Nagoya Laboratories, Pfizer Japan Incorporated, 5-2 Taketoyo, Aichi 470-2393, Japan

The 5-hydroxytryptamine type 4 receptors (5-HT4Rs) are involved in memory, cognition, feeding, respiratory control, and gastrointestinal motility through activation of a Gs/cAMP pathway. We have shown that 5-HT4R undergoes rapid and profound homologous uncoupling in neurons. However, no significant uncoupling was observed in COS-7 or HEK293 cells, which expressed either no or a weak concentration of GRK2, respectively. High expression of GRK2 in neurons is likely to be the reason for this difference because overexpression of GRK2 in COS-7 and HEK293 cells reproduced rapid and profound uncoupling of 5-HT4R. We have also shown, for the first time, that GRK2 requirements for uncoupling and endocytosis were very different. Indeed, {beta}-arrestin/dynamin-dependent endocytosis was observed in HEK293 cells without any need of GRK2 overexpression. In addition to this difference, uncoupling and {beta}-arrestin/dynamin-dependent endocytosis were mediated through distinct mechanisms. Neither uncoupling nor {beta}-arrestin/dynamin-dependent endocytosis required the serine and threonine residues localized within the specific C-terminal domains of the 5-HT4R splice variants. In contrast, a cluster of serines and threonines, common to all variants, was an absolute requirement for {beta}-arrestin/dynamin-dependent receptor endocytosis, but not for receptor uncoupling. Furthermore, {beta}-arrestin/dynamin-dependent endocytosis and uncoupling were dependent on and independent of GRK2 kinase activity, respectively. These results clearly demonstrate that the uncoupling and endocytosis of 5-HT4R require different GRK2 concentrations and involve distinct molecular events.


Received for publication, March 1, 2005 , and in revised form, May 24, 2005.

* This work was supported by grants from CNRS, the Génopole de Montpellier, and Pfizer Japan Inc. and by Grant LSHB-CT-2003-503337 from the European Community Sixth Framework Program. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{boxs} The on-line version of this article (available at http://www.jbc.org) contains Supplemental Table 1.

To whom correspondence should be addressed: Dépt. de Neurobiologie, Inst. de Génomique Fonctionnelle, 141 Rue de la Cardonille, Montpellier F-34094 Cedex 5, France. Tel.: 33-4-6714-2930; Fax: 33-4-6714-2910 or 33-4-6754-2432; E-mail: joel.bockaert{at}igf.cnrs.fr.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
Q. Liu, D. A. Dewi, W. Liu, M. S. Bee, and A. Schonbrunn
Distinct Phosphorylation Sites in the SST2A Somatostatin Receptor Control Internalization, Desensitization, and Arrestin Binding
Mol. Pharmacol., February 1, 2008; 73(2): 292 - 304.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Jean, G. Conductier, C. Manrique, C. Bouras, P. Berta, R. Hen, Y. Charnay, J. Bockaert, and V. Compan
Anorexia induced by activation of serotonin 5-HT4 receptors is mediated by increases in CART in the nucleus accumbens
PNAS, October 9, 2007; 104(41): 16335 - 16340.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
G. Barthet, B. Framery, F. Gaven, L. Pellissier, E. Reiter, S. Claeysen, J. Bockaert, and A. Dumuis
5-Hydroxytryptamine4 Receptor Activation of the Extracellular Signal-regulated Kinase Pathway Depends on Src Activation but Not on G Protein or beta-Arrestin Signaling
Mol. Biol. Cell, June 1, 2007; 18(6): 1979 - 1991.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.